APA (7th ed.) Citation

S, S., K, N., N, Y., H, N., Y, O., M, N., . . . T, T. (2019). Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC. International journal of clinical oncology, 24(5), 485. https://doi.org/10.1007/s10147-019-01396-z

Chicago Style (17th ed.) Citation

S, Sugawara, et al. "Japanese Subgroup Analysis of a Phase III Study of S-1 Versus Docetaxel in Non-small Cell Lung Cancer Patients After Platinum-based Treatment: EAST-LC." International Journal of Clinical Oncology 24, no. 5 (2019): 485. https://doi.org/10.1007/s10147-019-01396-z.

MLA (9th ed.) Citation

S, Sugawara, et al. "Japanese Subgroup Analysis of a Phase III Study of S-1 Versus Docetaxel in Non-small Cell Lung Cancer Patients After Platinum-based Treatment: EAST-LC." International Journal of Clinical Oncology, vol. 24, no. 5, 2019, p. 485, https://doi.org/10.1007/s10147-019-01396-z.